OrthoSpace

company

About

OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market.

  • 11 - 50

Details

Last Funding Type
Seed
Industries
Biotechnology,Medical,Medical Device
Founded date
Jan 1, 2009
Number Of Employee
11 - 50
Operating Status
Active

OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures.

The company’s first product has the CE mark and is currently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$15M
OrthoSpace has raised a total of $15M in funding over 2 rounds. Their latest funding was raised on Dec 1, 2016 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 1, 2016 Series Unknown $7M 1 Detail
May 19, 2015 Series Unknown $8M 1 Detail
Jan 1, 2011 Series A 1 Detail
Apr 5, 2009 Seed 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
OrthoSpace is funded by 2 investors. Triventures and Fuerst Technology Innovations are the most recent investors.
Investor Name Lead Investor Funding Round
Triventures Series Unknown
Fuerst Technology Innovations Series A